• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型铁螯合剂药物的研发。

The development of new iron-chelating drugs.

作者信息

Grady R W, Graziano J H, Akers H A, Cerami A

出版信息

J Pharmacol Exp Ther. 1976 Feb;196(2):478-85.

PMID:1255491
Abstract

2,3-Dihydroxybenzoic acid has been identified as a potentially useful iron-chelating drug. Accordingly, we have evaluated a series of derivatives of hydroxylated benzoic acids for their ability to induce iron excretion in the iron-overloaded rat. In addition, we have examined a number of hydroxamic acids and some other naturally occurring iron-chelating agents. Of the 26 benzoic acid derivatives studied, none appeared to be more effective than 2,3-dihydroxybenzoic acid, for reasons which are discussed. Rhodotorulic acid, a hydroxamic acid produced by and isolated from cultures of Rhodotorula pilimanae, was the most effective of all the compounds studied in inducing iron excretion. When administered parenterally, rholotorulic acid induced iron excretion via both the urinary and the fecal routes and was more than twice as potent (on a weight basis) as desferrioxamine. Two ferrous chelators, alpha, alpha-dipyridyl ad 1,10-phenanthroline, induced a moderate amount of iron excretion, suggesting that a pool of ferrous iron may be available for chelation.

摘要

2,3 - 二羟基苯甲酸已被确认为一种潜在有用的铁螯合剂。因此,我们评估了一系列羟基苯甲酸衍生物在铁过载大鼠中诱导铁排泄的能力。此外,我们还研究了一些异羟肟酸和其他一些天然存在的铁螯合剂。在所研究的26种苯甲酸衍生物中,由于文中讨论的原因,似乎没有一种比2,3 - 二羟基苯甲酸更有效。红酵母酸是由皮膜红酵母培养物产生并分离得到的一种异羟肟酸,是所有研究化合物中诱导铁排泄最有效的。经肠胃外给药时,红酵母酸通过尿液和粪便途径诱导铁排泄,并且(以重量计)效力是去铁胺的两倍多。两种亚铁螯合剂,α,α - 联吡啶和1,10 - 菲咯啉,诱导了适量的铁排泄,这表明可能存在可用于螯合的亚铁池。

相似文献

1
The development of new iron-chelating drugs.新型铁螯合剂药物的研发。
J Pharmacol Exp Ther. 1976 Feb;196(2):478-85.
2
The development of new iron-chelating drugs. II.新型铁螯合剂药物的研发。II.
J Pharmacol Exp Ther. 1978 Jun;205(3):575-65.
3
Rhodotorulic acid--investigation of its potential as an iron-chelating drug.红酵母氨酸——对其作为铁螯合药物潜力的研究。
J Pharmacol Exp Ther. 1979 Jun;209(3):342-8.
4
Evaluation of polymeric hydroxamic acid iron chelators for treatment of iron overload.用于治疗铁过载的聚合异羟肟酸铁螯合剂的评估。
J Pharmacol Exp Ther. 1985 Mar;232(3):644-9.
5
The identification of 2, 3-dihydroxybenzoic acid as a potentially useful iron-chelating drug.鉴定2,3 - 二羟基苯甲酸为一种潜在有用的铁螯合药物。
J Pharmacol Exp Ther. 1974 Sep;190(3):570-5.
6
The selection and evaluation of new chelating agents for the treatment of iron overload.
J Pharmacol Exp Ther. 1979 Jan;208(1):12-8.
7
Hemosiderosis in rodents and the effect of acetohydroxamic acid on urinary iron excretion.
Exp Hematol. 1986 Nov;14(10):971-4.
8
An in vivo evaluation of iron-chelating drugs derived from pyridoxal and its analogs.对源自吡哆醛及其类似物的铁螯合药物的体内评估。
J Pharmacol Exp Ther. 1982 May;221(2):399-403.
9
Iron retention and excretion in mice transfused with homologous or heterologous blood and treated with chelators.
Methods Find Exp Clin Pharmacol. 1982;4(3):151-9.
10
Evaluation of iron-chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron-chelating drug.
Br J Haematol. 1982 Jun;51(2):251-60.

引用本文的文献

1
Salvage Structures, Known as Iron Chelating Agents, Acquired from the Nature and Matured in the Labs.从自然界获取并在实验室中完善的挽救结构,即铁螯合剂。
Curr Med Chem. 2025;32(21):4225-4258. doi: 10.2174/0109298673264118231228042816.
2
New Insights into Aspirin's Anticancer Activity: The Predominant Role of Its Iron-Chelating Antioxidant Metabolites.阿司匹林抗癌活性的新见解:其铁螯合抗氧化代谢产物的主要作用
Antioxidants (Basel). 2024 Dec 29;14(1):29. doi: 10.3390/antiox14010029.
3
The Puzzle of Aspirin and Iron Deficiency: The Vital Missing Link of the Iron-Chelating Metabolites.
阿司匹林与缺铁之谜:铁螯合代谢物的关键缺失环节。
Int J Mol Sci. 2024 May 9;25(10):5150. doi: 10.3390/ijms25105150.
4
Chelators for Treatment of Iron and Copper Overload: Shift from Low-Molecular-Weight Compounds to Polymers.用于治疗铁和铜过载的螯合剂:从低分子量化合物向聚合物的转变
Polymers (Basel). 2021 Nov 17;13(22):3969. doi: 10.3390/polym13223969.
5
Salicylic acid analogues as chemical exchange saturation transfer MRI contrast agents for the assessment of brain perfusion territory and blood-brain barrier opening after intra-arterial infusion.水杨酸类似物作为化学交换饱和转移磁共振成像造影剂用于评估动脉内灌注后脑灌注区域和血脑屏障开放情况。
J Cereb Blood Flow Metab. 2016 Jul;36(7):1186-94. doi: 10.1177/0271678X16637882. Epub 2016 Mar 15.
6
Urease inhibition by hydroxamic acids.
Experientia. 1981 Mar 15;37(3):229-30. doi: 10.1007/BF01991625.